Syensqo completes acquisition of ceramides-specialist JinYoung Bio

Syensqo announced today the completion of the acquisition of JinYoung Bio, a specialty cosmetic ingredients supplier based in South Korea.

With this investment Syensqo (the company formed from Solvay’s speciality chemicals business) strengthens its position in beauty biotech with the addition of new renewable skin care specialties into its beauty care portfolio.

This acquisition reflects our deep commitment to innovation and our focus on sustainable solutions leveraging the power of biotechnology,” said Ilham Kadri, CEO of Syensqo. We are dedicated to making a meaningful impact in the beauty industry, addressing critical environmental and societal challenges with groundbreaking circular solutions.

The addition of JinYoung Bio’s technology will extend Syensqo’s product portfolio into biomimetic ceramides for skin care and hair care applications, as well as a range of biobased functional ingredients used in skin care and color cosmetic applications. Ceramides, the flagship product line within JinYoung Bio’s portfolio, are produced through biotechnology via a fermentation process.

Our aim is to provide our customers with advanced skin care solutions that harness the natural power of specialty ingredients like ceramides,” added Michael Radossich, President of the Consumer and Resources division at Syensqo. “This investment puts Syensqo at the forefront of leveraging the dynamic nature of ceramides, a hero ingredient in cosmetic products including the fast-growing dermocosmetics.

Syensqo will launch its first product from the ceramides line at NYSCC Suppliers’ Day in New York this week. Four functional ingredients are also scheduled for launch in Q2 2024.

Source link

About The Author

Scroll to Top